Human NK cell lines migrate differentially in vitro related to matrix interaction and MMP expression

Immunology and Cell Biology

Volumn 87, Issue 6, 2009, Pages 489-495

  Edsparr, Karin ^a   Johansson, Bengt R ^a   Goldfarb, Ronald H ^b,c   Basse, Per H ^d   Nannmark, Ulf ^a   Speetjens, Frank M ^e   Kuppen, Peter J K ^e   Lennernäs, Bo ^a   Albertsson, Per ^a,f,g  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF NORTH TEXAS   (United States)

^c Sopherion Therapeutics Inc   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Rigshospitalet   (Denmark)

^g SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Matrix; Migration; MMP; NK cell

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; MATRIGEL; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 16; MESSENGER RNA; MT6 MATRIX METALLOPROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CELL MIGRATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PROTEIN EXPRESSION;

BIOCOMPATIBLE MATERIALS; CELL LINE, TUMOR; CELL MOVEMENT; COLLAGEN; DIPEPTIDES; DRUG COMBINATIONS; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMANS; KILLER CELLS, NATURAL; LAMININ; LYMPHOCYTES, TUMOR-INFILTRATING; METALLOPROTEASES; PROTEOGLYCANS;

EID: 69049090790     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2009.35     Document Type: Article

References (24)

1. Albertsson PA, Basse PH, Hokland M, Goldfarb RH, Nagelkerke JF, Nannmark U et al. NK cells and the tumour microenvironment: implications for NK-cell function and antitumour activity. Trends Immunol 2003; 24: 603-609. (Pubitemid 37338529)
2. Basse P, Herberman RB, Nannmark U, Johansson BR, Hokland M, Wasserman K et al. Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases. J Exp Med 1991; 174: 479-488.
3. Hagenaars M, Ensink NG, Basse PH, Hokland M, Nannmark U, Eggermont AM et al. The microscopic anatomy of experimental rat CC531 colon tumour metastases: consequences for immunotherapy? Clin Exp Metastasis 2000; 18: 189-196.
4. Kuppen PJ, van der Eb MM, Jonges LE, Hagenaars M, Hokland ME, Nannmark U et al. Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer. Histochem Cell Biol 2001; 115: 67-72. (Pubitemid 32202055)
5. Yang Q, Hokland ME, Bryant JL, Zhang Y, Nannmark U, Watkins SC et al. Tumor-localization by adoptively transferred, interleukin-2-activated NK cells leads to destruction of well-established lung metastases. Int J Cancer 2003; 105: 512-519. (Pubitemid 36578556)
6. Kim MH, Kitson RP, Albertsson P, Nannmark U, Basse PH, Kuppen PJ et al. Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors. J Immunol 2000; 164: 5883-5889. (Pubitemid 30389834)
7. Kitson RP, Appasamy PM, Nannmark U, Albertsson P, Gabauer MK, Goldfarb RH. Matrix metalloproteinases produced by rat IL-2-activated NK cells. J Immunol 1998; 160: 4248-4253. (Pubitemid 28217279)
8. Zeng L, An S, Goetzl EJ. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor. Biochemistry 1996; 35: 7159-7164.
9. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003; 200: 448-464. (Pubitemid 36818245)
10. Albertsson P, Kim MH, Jonges LE, Kitson RP, Kuppen PJ, Johansson BR et al. Matrix metalloproteinases of human NK cells. In Vivo 2000; 14: 269-276.
11. Goda S, Inoue H, Umehara H, Miyaji M, Nagano Y, Harakawa N et al. Matrix metalloproteinase-1 produced by human CXCL12-stimulated natural killer cells. Am J Pathol 2006; 169: 445-458. (Pubitemid 44156307)
12. Ishida Y, Migita K, Izumi Y, Nakao K, Ida H, Kawakami A et al. The role of IL-18 in the modulation of matrix metalloproteinases and migration of human natural killer (NK) cells. FEBS Lett 2004; 569: 156-160. (Pubitemid 38844609)
13. Chuang SS, Kim MH, Johnson LA, Albertsson P, Kitson RP, Nannmark U et al. 2B4 stimulation of YT cells induces natural killer cell cytolytic function and invasiveness. Immunology 2000; 100: 378-383. (Pubitemid 30449953)
14. Berrier AL, Yamada KM. Cell-matrix adhesion. J Cell Physiol 2007; 213: 565-573.
15. Maenpaa A, Jaaskelainen J, Carpen O, Patarroyo M, Timonen T. Expression of integrins and other adhesion molecules on NK cells; impact of IL-2 on short- and long-term cultures. Int J Cancer 1993; 53: 850-855. (Pubitemid 23100132)
16. Albertsson P, Basse PH, Edsparr K, Kim MH, Goldfarb RH, Kitson RP et al. Differential locomotion of long- and short-term IL-2-activated murine natural killer cells in a model matrix environment. Scand J Immunol 2007; 66: 402-409. (Pubitemid 47407600)
17. Gong JH, Maki G, Klingemann HG. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 1994; 8: 652-658. (Pubitemid 24133034)
18. Maki G, Klingemann HG, Martinson JA, Tam YK. Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92. J Hematother Stem Cell Res 2001; 10: 369-383. (Pubitemid 32673241)
19. Tonn T, Becker S, Esser R, Schwabe D, Seifried E. Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92. J Hematother Stem Cell Res 2001; 10: 535-544. (Pubitemid 32756192)
20. Johansson BR, Nannmark U. Ultrastructure of interactions between activated murine natural killer cells and melanoma cells in an extracellular matrix (Matrigel) environment. Nat Immun 1996; 15: 98-106. (Pubitemid 27100001)
21. Johansson BR, Unger ML, Albertsson P, Casselbrant A, Nannmark U, Hokland M. Infiltration and lysis of tumour cell aggregates by adherent interleukin-2-activated natural killer cells is distinct from specific cytolysis. Nat Immun 1996; 15: 87-97. (Pubitemid 27100000)
22. Palmieri G, Gismondi A, Galandrini R, Milella M, Serra A, De Maria R et al. Interaction of natural killer cells with extracellular matrix induces early intracellular signalling events and enhances cytotoxic functions. Nat Immun 1996; 15: 147-153. (Pubitemid 27100005)
23. Yodoi J, Teshigawara K, Nikaido T, Fukui K, Noma T, Honjo T et al. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J Immunol 1985; 134: 1623-1630.
24. Lindeman JH, Hanemaaijer R, Mulder A, Dijkstra PD, Szuhai K, Bromme D et al. Cathepsin K is the principal protease in giant cell tumor of bone. Am J Pathol 2004; 165: 593-600. (Pubitemid 38971388)